BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 12825949)

  • 21. Rational design, synthesis and biological evaluation of thiadiazinoacridines: a new class of antitumor agents.
    Antonini I; Polucci P; Magnano A; Cacciamani D; Konieczny MT; Paradziej-Łukowicz J; Martelli S
    Bioorg Med Chem; 2003 Feb; 11(3):399-405. PubMed ID: 12517435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dimeric analogues of non-cationic tricyclic aromatic carboxamides are a new class of cytotoxic agents.
    Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    Anticancer Drug Des; 1999 Jun; 14(3):281-9. PubMed ID: 10500503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.
    Zhang Z; Yang Y; Zhang D; Wang Y; Qian X; Liu F
    Bioorg Med Chem; 2006 Oct; 14(20):6962-70. PubMed ID: 16828559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, DNA-cleaving properties and cytotoxicity of intercalating chelidamic acid derivatives.
    Searcey M; McClean S; Madden B; McGown AT; Wakelin LP
    Anticancer Drug Des; 1998 Dec; 13(8):837-55. PubMed ID: 10335263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
    Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
    Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of threading intercalators to target DNA.
    Howell LA; Gulam R; Mueller A; O'Connell MA; Searcey M
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6956-9. PubMed ID: 20980148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
    Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1997 Jun; 40(12):1919-29. PubMed ID: 9191970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of 9-anilinothiazolo[5,4-b]quinoline derivatives as potential antitumorals.
    Rodríguez-Loaiza P; Quintero A; Rodríguez-Sotres R; Solano JD; Lira-Rocha A
    Eur J Med Chem; 2004 Jan; 39(1):5-10. PubMed ID: 14987829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thermally inert metal ammines as light-inducible DNA-targeted agents. Synthesis, photochemistry, and photobiology of a prototypical rhodium(III)-intercalator conjugate.
    Barry CG; Turney EC; Day CS; Saluta G; Kucera GL; Bierbach U
    Inorg Chem; 2002 Dec; 41(26):7159-69. PubMed ID: 12495358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly stable phenanthridinium frameworks as a new class of tunable DNA binding agents with cytotoxic properties.
    Parenty AD; Smith LV; Guthrie KM; Long DL; Plumb J; Brown R; Cronin L
    J Med Chem; 2005 Jul; 48(14):4504-6. PubMed ID: 15999988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N4-(omega-Aminoalkyl)-1-[(omega-aminoalkyl)amino]-4- acridinecarboxamides: novel, potent, cytotoxic, and DNA-binding agents.
    Antonini I; Polucci P; Kelland LR; Spinelli S; Pescalli N; Martelli S
    J Med Chem; 2000 Dec; 43(25):4801-5. PubMed ID: 11123989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of benzimidazole acridine derivatives as potential DNA-binding and apoptosis-inducing agents.
    Gao C; Li B; Zhang B; Sun Q; Li L; Li X; Chen C; Tan C; Liu H; Jiang Y
    Bioorg Med Chem; 2015 Apr; 23(8):1800-7. PubMed ID: 25778766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, cytotoxic activities and proposed mode of binding of a series of bis([(9-oxo-9,10-dihydroacridine-4-carbonyl)amino]alkyl) alkylamines.
    Braña MF; Casarrubios L; Domínguez G; Fernández C; Pérez JM; Quiroga AG; Navarro-Ranninger C; de Pascual-Teresa B
    Eur J Med Chem; 2002 Apr; 37(4):301-13. PubMed ID: 11960665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological and toxicological aspects of new imidazoacridinone antitumor agents.
    Berger B; Marquardt H; Westendorf J
    Cancer Res; 1996 May; 56(9):2094-104. PubMed ID: 8616856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors.
    David-Cordonnier MH; Hildebrand MP; Baldeyrou B; Lansiaux A; Keuser C; Benzschawel K; Lemster T; Pindur U
    Eur J Med Chem; 2007 Jun; 42(6):752-71. PubMed ID: 17433851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular recognition of DNA by rigid [N]-polynorbornane-derived bifunctional intercalators: synthesis and evaluation of their binding properties.
    Van Vliet LD; Ellis T; Foley PJ; Liu L; Pfeffer FM; Russell RA; Warrener RN; Hollfelder F; Waring MJ
    J Med Chem; 2007 May; 50(10):2326-40. PubMed ID: 17429957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5,7-Disubstituted analogues of the mixed topoisomerase I/II poison N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA): DNA binding and patterns of cytotoxicity.
    Spicer JA; Finlay GJ; Baguley BC; Velea L; Graves DE; Denny WA
    Anticancer Drug Des; 1999 Feb; 14(1):37-45. PubMed ID: 10363026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyrimido [4,5,6-kl] acridines, a new class of potential anticancer agents. Synthesis and biological evaluation.
    Antonini I; Polucci P; Cola D; Bontemps-Gracz M; Pescalli N; Menta E; Martelli S
    Anticancer Drug Des; 1996 Jun; 11(4):339-49. PubMed ID: 8679056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of polyamine architecture on the transport and topoisomerase II inhibitory properties of polyamine DNA-intercalator conjugates.
    Wang L; Price HL; Juusola J; Kline M; Phanstiel O
    J Med Chem; 2001 Oct; 44(22):3682-91. PubMed ID: 11606133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
    Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
    Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.